MDGL: A Promising Play In The Weight Loss Drug Space
November 22, 2024 at 21:10 PM EST
The launch of Madrigal Pharmaceuticals Inc.’s NASH drug Rezdiffra exceeded all expectations in the recent quarterly earnings release. The stock rose more than 50% in a few days – and the company now has a market cap of close to $8 billion.
